ENTITY
CStone Pharmaceuticals

CStone Pharmaceuticals (2616 HK)

107
Analysis
Health CareHong Kong
CStone Pharmaceuticals operates as a biotechnology company. The Company develops immuno-oncology and molecularly targeted drugs to address unmet medical needs for cancer patients. CStone Pharmaceuticals serves customers worldwide.
more
11 Feb 2020 00:32

InnoCare Pharma IPO Initiation: Promising Prognosis

InnoCare Pharma Ltd (1576300D CH) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...

Logo
500 Views
Share
19 Aug 2019 10:05

CStone Pharma's (基石药业) Lock-Up Expiry - A Review of Valuation

Lock-up restriction for Cstone Pharma's pre-IPO investors and cornerstone investors will expire on August 26th. As we expect roughly USD 1 billion...

Logo
539 Views
Share
18 Aug 2019 15:22

🇨🇳🇭🇰 That Was The Week That Was • Hong Kong/China - 12th~18th August 2019 @Smartkarma

• TW3 HONG KONG/CHINA 12~18 AUGUST •The weight of this week's 28 China/Hong Kong Insights was surprisingly more bullish in its tone (18 bull/10...

Logo
467 Views
Share
15 Aug 2019 13:27

CStone Pharma's (基石药业) Lock-Up Expiry - Analysis of Potential Selling Shareholders

Lock-up restriction for Cstone Pharma's pre-IPO investors and cornerstone investors will expire on August 26th. As we expect roughly USD 1 billion...

Logo
669 Views
Share
14 Aug 2019 16:45

CStone Pharma's (基石药业) Lock-Up Expiry - Lack of Material Newsflow for Core Drug Candidates

Lock-up restriction for Cstone Pharma's pre-IPO investors and cornerstone investors will expire on August 26th. As we expect roughly USD 1 billion...

Logo
678 Views
Share
x